Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
Public ClinicalTrials.gov record NCT04357730. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection: A Phase 2a Clinical Trial
Study identification
- NCT ID
- NCT04357730
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Denver Health and Hospital Authority
- Other
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Interventions
- Alteplase 50 MG [Activase] Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 13, 2020
- Primary completion
- Mar 20, 2021
- Completion
- Sep 29, 2021
- Last update posted
- Jan 19, 2022
2020 – 2021
United States locations
- U.S. sites
- 9
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scripps Memorial Hospital La Jolla | La Jolla | California | 92037 | — |
| University of Colorado, Denver | Aurora | Colorado | 80045 | — |
| Denver Health Medical Center | Denver | Colorado | 80204 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| St. Mary's Medical Center | West Palm Beach | Florida | 33407 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Long Island Jewish Medical Center | New York | New York | 11040 | — |
| Methodist Dallas Medical Center | Dallas | Texas | 75203 | — |
| Ben Taub Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04357730, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2022 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04357730 live on ClinicalTrials.gov.